Search filters

List of works by Raffaele Califano

A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours

scientific article

Afatinib use in non-small cell lung cancer previously sensitive to epidermal growth factor receptor inhibitors: the United Kingdom Named Patient Programme.

scientific article published on 10 April 2014

Availability of EGFR mutation status at first oncology consultation for advanced non-squamous non-small cell lung cancer patients. A pilot experience from the Christie.

scientific article published on 21 September 2013

Beyond EGFR and ALK inhibition: unravelling and exploiting novel genetic alterations in advanced non small-cell lung cancer.

scientific article published on 28 March 2015

Biomarker utility of circulating tumor cells in metastatic cutaneous melanoma

scientific article published on 6 December 2012

Can EBUS-TBNA provide an accurate diagnosis in patients found to have enlarged or FDG-avid lymph nodes during surveillance of previously treated lung cancer? A retrospective study.

scientific article published in April 2015

Clinical outcomes with erlotinib in patients with epidermal growth factor receptor mutation.

scientific article published on June 2012

Current and future therapeutic approaches for the treatment of small cell lung cancer.

scientific article published on 15 March 2018

Durvalumab after chemo-radiotherapy in stage III non-small cell lung cancer.

scientific article published in April 2018

Expert Consensus on the Management of Adverse Events from EGFR Tyrosine Kinase Inhibitors in the UK

scientific article

First-line immune checkpoint blockade for advanced non-small-cell lung cancer: Travelling at the speed of light

scientific article published on 19 June 2019

Immune Checkpoint Blockade: A New Era for Non-Small Cell Lung Cancer.

scientific article

Immune checkpoint blockade for advanced non-small cell lung cancer: challenging clinical scenarios.

scientific article

Immune checkpoint blockade in small cell lung cancer

scientific article published on 22 August 2019

Immune checkpoint blockade in small cell lung cancer: is there a light at the end of the tunnel?

scientific article

Immunotherapy with checkpoint inhibitors for lung cancer: novel agents, biomarkers and paradigms

scientific article

Lung cancer after treatment for breast cancer

scientific article published on 10 June 2010

Management of NSCLC Disease Progression After First-Line EGFR Tyrosine Kinase Inhibitors: What Are the Issues and Potential Therapies?

scientific article published on 29 April 2016

Management of ceritinib therapy and adverse events in patients with ALK-rearranged non-small cell lung cancer.

scientific article published on 09 June 2017

Management of small cell lung cancer: recent developments for optimal care

scientific article published on March 2012

Omitting elective nodal irradiation during thoracic irradiation in limited-stage small cell lung cancer--evidence from a phase II trial

scientific article published on 19 October 2011

Outcomes of Platinum-Sensitive Small-Cell Lung Cancer Patients Treated With Platinum/Etoposide Rechallenge: A Multi-Institutional Retrospective Analysis

scientific article published on 24 April 2015

Outcomes of octogenarian (≥80 yo) patients with advanced non-small cell lung cancer (NSCLC): A single institution experience at the Christie Hospital

article

Outcomes of small-cell lung cancer patients treated with second-line chemotherapy: a multi-institutional retrospective analysis

scientific article

Overcoming resistance to first/second generation epidermal growth factor receptor tyrosine kinase inhibitors and ALK inhibitors in oncogene-addicted advanced non-small cell lung cancer

scientific article

Phase III randomised trial of doxorubicin-based chemotherapy compared with platinum-based chemotherapy in small-cell lung cancer

scientific article published on August 2008

Predictive biomarkers of response for immune checkpoint inhibitors in non-small-cell lung cancer

scientific article published on 05 December 2018

Prise en charge du cancer bronchique à petites cellules (CPC) (localisé et étendu)

Professional burnout in European young oncologists: results of the European Society for Medical Oncology (ESMO) Young Oncologists Committee Burnout Survey.

scientific article published on 25 April 2017

Randomised phase II trial of 4 dose levels of single agent docetaxel in performance status (PS) 2 patients with advanced non-small cell lung cancer (NSCLC): DOC PS2 trial. Manchester lung cancer group

scientific article

Role of mesenchymal-epithelial transition amplification in resistance to anti-epidermal growth factor receptor agents

scientific article

SELECT-3: a phase I study of selumetinib in combination with platinum-doublet chemotherapy for advanced NSCLC in the first-line setting

scientific article published on 24 August 2017

Targeted Therapy For RET-Rearranged Non-Small Cell Lung Cancer: Clinical Development And Future Directions

scientific article published on 24 September 2019

Targeted therapies in small cell lung cancer: a review

scientific article

The Role of Targeted Agents and Immunotherapy in Older Patients with Non-small Cell Lung Cancer

scientific article published on 01 September 2018

The TORCH trial.

scientific article

The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO).

scientific article published on 13 December 2013

The role of molecular analyses in the diagnosis and treatment of non-small-cell lung carcinomas

scientific article published on 13 November 2013

Therapies in the pipeline for small-cell lung cancer.

scientific article published on 20 June 2016

Third-line chemotherapy in small-cell lung cancer: an international analysis.

scientific article

Type III or allosteric kinase inhibitors for the treatment of non-small cell lung cancer

scientific article published on 28 March 2014

Use of G-CSF during concurrent chemotherapy and thoracic radiotherapy in patients with limited-stage small-cell lung cancer safety data from a phase II trial

scientific article

Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee.

scientific article published on 16 March 2014

Paulina is supported by:

About Paulina

Help